Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Gilead’s Kite Hopes To Reinforce Commercial CAR-T Lead With Yescarta Data

Jun 09 2023

• By Alaric DeArment

Gilead and Kite at ASCO 2023 • Source: Alaric DeArment

Related Content

Gilead CAR-T Joins Billion-Dollar Club As Biktarvy Sales Cross $10bn Mark

Feb 03 2023

Gilead Keeps Focus On HIV, Long-Acting Drugs And Growth Through Oncology

Feb 01 2023

Deal With Arcellx Gives Gilead New Beachhead In Multiple Myeloma

Dec 09 2022

Related Companies

Gilead Sciences, Inc.

Novartis AG

Bristol Myers Squibb Company

Arcellx, Inc.

Additional Topics

ImmunoOncology Commercial ASCO Interviews BioPharmaceutical

More from ASCO

More from Conferences

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window